“Since its launch over 20 years ago, we have constantly listened to our customers’ feedback, which has driven continuous design improvements for NovaSure,” said Jan Verstreken, Group President, ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...
Hologic, one of the few companies to emerge from the pandemic stronger than it was before, has scored regulatory approvals in Canada and Europe for an updated version of its NovaSure V5 endometrial ...
0001 Novasure Endometrial Ablation Device (NS2007US) 1 (Brand Name or Equal) SUBTOTAL (Products) This solicitation requires registration with the System for Award Management (SAM) prior to award, ...
Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here. With a 20-Year Legacy, the NovaSure System is the Most Trusted in Global Endometrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results